TVM Capital GmbH

Type: Company

Name: TVM Capital GmbH

First reported May 22 2013 - Updated May 22 2013 - 1 reports

Dubai’s Boom-Time Boys: Where Are They Now?

Chris O Donnell, former boss of Nakheel (right) with Donald Trump.Then: Nakheel CEONow: President, Al Futtaim Real Estate GroupThis beleaguered exec hit the headlines during the property boom when he led Nakheel to propose developments including The Palm ... [Published Gulf Business - May 22 2013]

Entities: Dubai, Nakheel Group, Sameer Al Ansari, Real Estate, TVM Capital GmbH

First reported May 01 2013 - Updated May 01 2013 - 1 reports

Healthcare fund TVM Capital MENA chasing control deals in India

The fund is looking to sew a few deals in the country from its new emerging markets fund, which is expected to complete fundraising by the end of 2013.Healthcare-focused private equity firm TVM Capital MENA is chasing small and mid-size control deals ... [Published VC Circle - May 01 2013]

Entities: TVM Capital GmbH, India, Health Care

First reported Apr 30 2013 - Updated Apr 30 2013 - 1 reports

Bourn Hall investing $100M in Indian arm to open new fertility clinics

Private equity firm TVM Capital MENA owns 70% stake in Bourn Hall International.UK-based healthcare services firm Bourn Hall International is investing $100 million (around Rs 540 crore) in its Indian subsidiary to finance an expansion plan to set up ... [Published VC Circle - Apr 30 2013]

Entities: TVM Capital GmbH, In Vitro Fertilisation, Fertility

First reported Apr 25 2013 - Updated Apr 25 2013 - 2 reports

Founding partner of TVM Capital MENA addresses audiences at 'Women Who Inspire' panel in US

Hoda Abou-Jamra, one of the founding partners of private equity firm TVM Capital MENA, has spoken to US audiences about some of the challenges facing the healthcare industry in the US and the Middle East. She also covered some of the latest trends and ... [Published AME Info - Apr 25 2013]

Entities: TVM Capital GmbH, Health Care, Portfolio Companies, In Vitro Fertilisation

First reported Jan 22 2013 - Updated Jan 23 2013 - 1 reports

TVM Life Science Ventures Backs Kaneq Bioscience

TVM Life Science Ventures VII has put an undisclosed amount of money into Montreal-based Kaneq Bioscience Ltd. Kaneq is a biotechnology company focused on developing treatments for type 2 diabetes. PRESS RELEASE TVM Life Science Ventures VII today ... [Published PE Hub News - Jan 22 2013]

Entities: Life Science, TVM Capital GmbH, Montreal, Diabetes

Quotes

Speaking at the event Ms Abou-Jamra, said, "It is an honour to have been asked to participate in today's 'Women Who Inspire' panel and I think it is vital that we highlight the growing role women are playing in global healthcare delivery as strategists and policy makers."

Founding partner of TVM Capital MENA addresses audiences at 'Women Who Inspire' panel in US [Published AME Info - Apr 25 2013]

...The chips independently developed by Rockchip had won the "China chip” for five consecutive years. The headquarters of Rockchip is in Fuzhou, responsible for designing and developing. We have three branches in Beijing, Shanghai and Shenzhen, with focus on programs and marketing. For more information, please visit www.rock-chips.com."

Rockchip Leverages Arteris FlexNoC Interconnect IP for Next Generation SoCs [Published Design and Reuse - Apr 16 2013]

...advance our fully personalized immunotherapy for metastatic renal cell carcinoma," said Jeff Abbey, Chief Executive Officer of Argos Therapeutics. "The capital we raised in April together with this recognition will help bring AGS-003 to market for the thousands of advanced kidney cancer patients in the US each year." About the Arcelis? Technology Arcelis is a fully personalized, active immunotherapy technology that captures all antigens, including mutated and variant...

Southeast BIO Recognizes Argos Therapeutics with the "2012 Southeast BIO Deal of the Year: Ventur ... [Published GlobeNewswire - Nov 02 2012]

More Content

sort by: Date \| Relevance
Dubai’s Boom-Time Boys: Where Are They Now? [Published Gulf Business - May 22 2013]
#OI2Dublin: Innovation about execution, not jus... [Published Silicon Republic - May 20 2013]
Financings of the Fortnight Waits For Public In... [Published The IN VIVO Blog - May 17 2013]
ARM and Arteris Extend Partnership [Published Crescendo Venture Management - May 14 2013]
Healthcare fund TVM Capital MENA chasing contro... [Published VC Circle - May 01 2013]
Bourn Hall investing $100M in Indian arm to ope... [Published VC Circle - Apr 30 2013]
Founding partner of TVM Capital MENA addresses ... [Published AME Info - Apr 25 2013]
Founding Partner of TVM Capital MENA Addresses ... [Published Zawya.com - Apr 25 2013]
ARM and Arteris Extend Partnership to Deliver A... [Published TickerTech.com - Apr 17 2013]
Rockchip Leverages Arteris FlexNoC Interconnect... [Published Design and Reuse - Apr 16 2013]
Enanta Pharmaceuticals Announces IPO pricing [Published PE Hub News - Mar 21 2013]
Probiodrug Sponsoring Symposium to Share Resear... [Published Yahoo! Finance - Mar 06 2013]
Financings of the Fortnight Jumps On Board The ... [Published The IN VIVO Blog - Jan 25 2013]
TVM Life Science Ventures Backs Kaneq Bioscience [Published PE Hub News - Jan 22 2013]
Financing Deal of the Year Nominee: bluebird bio [Published The IN VIVO Blog - Dec 18 2012]
Southeast BIO Recognizes Argos Therapeutics wit... [Published GlobeNewswire - Nov 02 2012]
UK-based Bourn Hall Clinic opens facility in Gu... [Published PharmaBiz - Sep 07 2012]

sort by: Date \| Relevance
Financings of the Fortnight Waits For Public In... [Published The IN VIVO Blog - May 17 2013] It’s been another IPO-intensive couple of weeks here at FOTF HQ. We keep looking for other things to write about, but sometimes the fastest shave on deadline is with Occam’s razor. Or something like that. We didn't exactly ace our philosophy classes ...
Financings of the Fortnight Jumps On Board The ... [Published The IN VIVO Blog - Jan 25 2013] We're here to point you toward the newly published 2012 A-List , dear readers, but first let's note some big numbers. US listed biotechs raised at least $1.8 billion in stock and debt sales the past couple weeks. We've highlighted two below, Onyx ...
Financing Deal of the Year Nominee: bluebird bio [Published The IN VIVO Blog - Dec 18 2012] It's time for the IN VIVO Blog's Fifth Annual Deal of the Year! competition. This year we're once again presenting awards in three categories to highlight the most interesting and creative deal making solutions of the year. The categories are: M&A ...